[국제]US FDA Advisory Committee Recommends Approval for Emergency Use of Pfizer Vaccine

[앵커]

The US Food and Drug Administration and the FDA advisory committee recommended the urgent use of Pfizer’s COVID-19 vaccine after eight hours of discussion.

The FDA is expected to approve the urgent use of the Pfizer vaccine in a few days based on the Advisory Committee’s recommendations.

This is a report from the Washington correspondent, Taewook Kang.

[기자]

The US FDA Advisory Committee was conducted with outside experts.

This is to deliberate on whether to recommend the urgent use of the vaccine requested by Pfizer.

[도런 핀크 / 미국 FDA 부국장 : 우리는 위원회가 오늘 제출된 계획과 긴급사용이 신청된 화이자-바이오엔테크 백신을 접종하게 될 사람들의 안전성과 효과에 대한 추가 평가를 위한 브리핑 문서에 있는 어떠한 차이도 논의하기를 바랍니다.]

Discussions continued based on the results of the clinical trials and the FDA’s internal review.

Some argued that the safety of the vaccine needs to be further monitored and the issue was pointed out that there is a lack of data on whether teens and others may be right.

There were also discussions about cases of reported side effects in the UK, including allergy symptoms.

It then issued a recommendation to approve emergency use by vote.

[스티븐 한 / 미국 FDA 국장 : 전국적으로 백신이 보급되면 이 나라에 큰 희망이, 큰 빛이 생기는 것입니다. 그리고 우리는 모두 이것을 극복하고 더 정상적이고 건강한 삶을 살기를 고대하고 있다고 생각합니다.]

The following procedure is final FDA approval based on the recommendations of the advisory committee.

The US government’s high-speed operations team will begin shipping the vaccine with approval.

However, CNN explained that actual vaccination does not take place until the Centers for Disease Control and Prevention and CDC make a decision again through the advisory committee.

YTN Kang Tae-wook from Washington[[email protected]]it is.

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]